drugset / Trial / NCT07525427

Bactericidal Activity of TBD09 in Combination With Other Drugs in Pulmonary Tuberculosis

NCT07525427

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate if TBD09 in combination with other active agents in adults with drug sensitive pulmonary tuberculosis has potential to be safe and effective.

Timeline

Start
2026-04-14
Primary completion
2026-11-05
Completion
2026-11-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Linezolid Other / unclassified 600 mg
Subject TBD09 Unknown 100 mg
Subject TBD09 Unknown 300 mg
Subject TBD09 Unknown 500 mg
Background Bedaquiline Small molecule 200 mg
Background Pretomanid Small molecule 200 mg